LncRNAs in Cardiovascular Development & Disease

Long noncoding rnas (lncrnas) are emerging as powerful regulators of cardiac development and disease. Here is the latest research.

August 9, 2020
Open Access

Endogenous Retrovirus-Derived lncRNA BANCR Promotes Cardiomyocyte Migration in Humans and Non-human Primates

Developmental Cell
Kitchener D WilsonJoseph C Wu
August 29, 2020
Open Access

Microarray analysis of long non-coding RNA expression profiles in Marfan syndrome

Experimental and Therapeutic Medicine
Lizhong GuJue Wang
August 13, 2020

The lncRNA ANRIL regulates endothelial dysfunction by targeting the let-7b/TGF-βR1 signalling pathway

Journal of Cellular Physiology
Xianglan LiuBo Yu
December 19, 2020
Open Access

Autophagy in cardiovascular diseases: role of noncoding RNAs

Molecular Therapy. Nucleic Acids
Jinning GaoKai Shao
August 11, 2020
Open Access

The Long Non-coding Road to Atherosclerosis

Current Atherosclerosis Reports
Tatjana Josefs, Reinier A Boon
July 24, 2020
Open Access

Long Noncoding RNAs in Atherosclerosis and Vascular Injury: Pathobiology, Biomarkers, and Targets for Therapy

Arteriosclerosis, Thrombosis, and Vascular Biology
Jacob B Pierce, Mark W Feinberg
November 25, 2020

Transcribed ultraconserved region uc.242 is a novel regulator of cardiomyocyte hypertrophy induced by angiotensin II

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
Ying GuGuokun Wang
July 10, 2020
Open Access

A Long Noncoding RNA CHAIR protects the heart from pathological stress

Clinical Science
Yanxia QianJunhong Wang
August 25, 2020

LncRNA OIP5-AS1 contributes to the progression of atherosclerosis by targeting miR-26a-5p through AKT/NF-κB pathway

Journal of Cardiovascular Pharmacology
Mingming RenChun Ouyang
December 23, 2020

Mechanisms of action of metformin and its regulatory effect on microRNAs related to angiogenesis

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Gang WangMao Luo

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved